# Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia

> **NCT07640256** · PHASE4 · COMPLETED · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 50 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Peribulbar anesthesia with 0.5% bupivacaine and 2% lidocaine
- **DRUG:** Tetracaine 5% drops

## Key facts

- **NCT ID:** NCT07640256
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2024-03-21
- **Final completion:** 2024-06-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640256, "Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07640256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*